Management cost of acute limb ischaemia

British Journal of Surgery

Volumn 83, Issue 10, 1996, Pages 1390-1393

  Braithwaite, B D ^a,b   Jones, L ^a   Heather, B P ^a   Birch, P A ^a   Earnshaw, J J ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANGIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH ECONOMICS; HOSPITAL COST; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0029803788     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800831020     Document Type: Article

References (8)

1. Ouriel K, Shortell CK, DeWeese JA et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischaemia. J Vasc Surg 1994; 19: 1021-30.
2. Braithwaite BD, Jones L, Buckenham TM et al. Accelerated thrombolysis with high-dose bolus tissue plasminogen activator is as safe and effective as low-dose infusions: results of a randomized trial. Br J Surg 1996; 83: 560-1 (Abstract).
3. Earnshaw JJ, Beard JD. Intraoperative use of thrombolytic agents. BMJ 1993; 307: 638-9.
4. Dregelid EB, Strangeland LB, Eide GE, Trippestad A. Patient survival and limb prognosis after arterial embolectomy. Eur J Vasc Surg 1987; 1: 263-71.
5. Blaisdell FW, Steel M, Allen RE. Management of low extremity arterial ischaemia due to embolism and thrombosis. Br J Surg 1978; 84: 822-31.
6. Dacey LJ, Dow RW, McDaniel MD, Walsh DB, Zwolak RM, Cronenwett JL. Cost-effectiveness of intra-arterial thrombolytic therapy. Arch Surg 1988; 123: 1218-23.
7. Hoch JR, Tullis MJ, Archer CW et al. Thrombolysis versus surgery as the initial management for native artery occlusion; efficacy, safety, and cost. Surgery 1994; 116: 649-57.
8. Szczepura A. Finding a way through the cost and benefit maze. BMJ 1994; 309: 1314-15.